139 related articles for article (PubMed ID: 35760586)
1. ACUTE RETINAL NECROSIS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT. A CASE REPORT.
Šulavíková Z; Anwarzai J; Krásnik V
Cesk Slov Oftalmol; 2022; 78(3):144-148. PubMed ID: 35760586
[TBL] [Abstract][Full Text] [Related]
2. Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report.
Zhang ZY; Liu XY; Jiang T
BMC Ophthalmol; 2020 Jun; 20(1):247. PubMed ID: 32571253
[TBL] [Abstract][Full Text] [Related]
3. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
4. [A cost-effectiveness study of dexamethasone implants in macular edema].
Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
[TBL] [Abstract][Full Text] [Related]
5. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
Bernard Y; Bonnin N; Farguette F; Chiambaretta F
J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
[TBL] [Abstract][Full Text] [Related]
6. SAFETY OF CONSECUTIVE SAME-DAY BILATERAL INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX).
Kapoor KG; Colchao JB
Retin Cases Brief Rep; 2020; 14(2):200-202. PubMed ID: 29155696
[TBL] [Abstract][Full Text] [Related]
7. Secondary glaucoma after intravitreal dexamethasone implant (Ozurdex) injection in patients with retinal disorder: A retrospective study.
Sweta VD; Shibi Dev BN; Sandhya R
Indian J Ophthalmol; 2022 Feb; 70(2):585-589. PubMed ID: 35086242
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone intravitreal implant (OZURDEX
Massa H; Georgoudis P; Panos GD
Ther Deliv; 2019 Jun; 10(6):343-351. PubMed ID: 31184554
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
[TBL] [Abstract][Full Text] [Related]
10. OZURDEX® (Dexamethasone Intravitreal Implant) 0.7 mg as Initial Therapy in Pseudophakic Patients With Diabetic Macular Edema, Macular Edema Following Retinal Vein Occlusion, and Noninfectious Posterior Segment Uveitis: A Case-Based Discussion.
Retina; 2019 Jun; 39 Suppl 1():S1-S28. PubMed ID: 31206423
[No Abstract] [Full Text] [Related]
11. Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report.
Ekinci C; Kayıran A; Özdemir H
Turk J Ophthalmol; 2019 Jun; 49(3):175-177. PubMed ID: 31245982
[TBL] [Abstract][Full Text] [Related]
12. Quantification of fluid resorption from diabetic macular oedema with foveal serous detachment after dexamethasone intravitreal implant (Ozurdex
Hodzic-Hadzibegovic D; Ba-Ali S; Valerius M; Lund-Andersen H
Acta Ophthalmol; 2017 May; 95(3):324-325. PubMed ID: 27778454
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors.
Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I
Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480
[TBL] [Abstract][Full Text] [Related]
14. Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant.
Kucukevcilioglu M; Eren M; Yolcu U; Sobaci G
Arq Bras Oftalmol; 2015; 78(2):118-9. PubMed ID: 25945535
[TBL] [Abstract][Full Text] [Related]
15. Ozurdex for refractory macular edema secondary to diabetes, vein occlusion, uveitis and pseudophakia.
Teja S; Sawatzky L; Wiens T; Maberley D; Ma P
Can J Ophthalmol; 2019 Oct; 54(5):540-547. PubMed ID: 31564342
[TBL] [Abstract][Full Text] [Related]
16. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.
Scaramuzzi M; Querques G; Spina CL; Lattanzio R; Bandello F
Retina; 2015 Jun; 35(6):1216-22. PubMed ID: 25574787
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
Ferrini W; Ambresin A
Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
[TBL] [Abstract][Full Text] [Related]
18. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
[TBL] [Abstract][Full Text] [Related]
19. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
Bakri SJ; Omar AF
J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
[TBL] [Abstract][Full Text] [Related]
20. [Early efficacy of dexamethasone implant (OZURDEX
Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
